MMWR Vol. 66 / No. SS-15

By Newsroom America Feeds at 7 Sep 2017


"MMWR" Surveillance Summaries Vol. 66, No. SS-15 September 08, 2017


In this report

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 1864 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas United States, 20092014 Katherine Kolor, PhD; Zhuo Chen, PhD; Scott D. Grosse, PhD; et al.

Genetic testing for breast cancer 1 ("BRCA1") and breast cancer 2 ("BRCA2") gene mutations can identify women at increased risk for breast and ovarian cancer, and the results can be used to select preventive interventions and guide treatment. Medical claims data were used to estimate rates of "BRCA" testing and receipt of preventive interventions after "BRCA" testing among women aged 1864 years with employer-sponsored health insurance in metropolitan and nonmetropolitan areas of the United States, nationally and regionally.

"MMWR" Masthead

Stay up-to-date with the "voice of CDC" by downloading the "MMWR" Express app for fast access to "MMWR":

*Department of Health and Human Services Centers for Disease Control and Prevention*

The CDC has reached over 1.4 million subscribers. Thank you for your support.

Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact

Dept of Health and Human Services Logo 24/7 - Saving Lives, Protecting People, Saving Money. CDC on Facebook on Twitter YouTube Channel Instagram Pinterest CDC Vital Signs Learn about the latest public health data. Read CDC Vital Signs


[D] [Digg] [FB] [R] [SU] [Tweet] [G]